{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T09:25:43Z","timestamp":1791278743491,"version":"4.1.0"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1097\/bor.0b013e32835b15f7","type":"journal-article","created":{"date-parts":[[2012,11,17]],"date-time":"2012-11-17T08:15:00Z","timestamp":1353140100000},"page":"10-18","source":"Crossref","is-referenced-by-count":99,"title":["Cryoglobulinemia vasculitis"],"prefix":"10.1097","volume":"25","author":[{"given":"Benjamin","family":"Terrier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrice","family":"Cacoub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-5-20210128","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1002\/1529-0131(199910)42:10<2204::AID-ANR24>3.0.CO;2-D","article-title":"Extrahepatic manifestations of chronic hepatitis C. MULTIVIRC Group. Multidepartment Virus C.","volume":"42","author":"Cacoub","year":"1999","journal-title":"Arthritis Rheum"},{"key":"R2-5-20210128","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1097\/00005792-200107000-00004","article-title":"Cryoglobulinemia: study of etiologic factors and clinical and immunologic features in 443 patients from a single center.","volume":"80","author":"Trejo","year":"2001","journal-title":"Medicine (Baltimore)"},{"key":"R3-5-20210128","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1001\/archinte.166.19.2101","article-title":"Increased risks of lymphoma and death among patients with nonhepatitis C virus-related mixed cryoglobulinemia.","volume":"166","author":"Saadoun","year":"2006","journal-title":"Arch Intern Med"},{"key":"R4-5-20210128","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/0002-9343(74)90852-3","article-title":"Biologic and clinical significance of cryoglobulins: a report of 86 cases.","volume":"57","author":"Brouet","year":"1974","journal-title":"Am J Med"},{"key":"R5-5-20210128","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0002-9343(80)90390-3","article-title":"Mixed cryoglobulinemia: clinical aspects and long-term follow-up of 40 patients.","volume":"69","author":"Gorevic","year":"1980","journal-title":"Am J Med"},{"key":"R6-5-20210128","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1136\/jcp.55.1.4","article-title":"Cryoglobulins.","volume":"55","author":"Ferri","year":"2002","journal-title":"J Clin Pathol"},{"key":"R7-5-20210128","doi-asserted-by":"crossref","first-page":"5996","DOI":"10.1182\/blood-2011-12-396028","article-title":"Management of noninfectious mixed cryoglobulinemia vasculitis: data from 242 cases included in the CryoVas survey.","volume":"119","author":"Terrier","year":"2012","journal-title":"Blood"},{"key":"R10-5-20210128","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1002\/art.30319","article-title":"Prognostic factors in patients with hepatitis C virus infection and systemic vasculitis.","volume":"63","author":"Terrier","year":"2011","journal-title":"Arthritis Rheum"},{"key":"R11-5-20210128","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/0002-9343(66)90200-2","article-title":"Cryoglobulinemia-a clinical and laboratory study. II. Cryoglobulins with rheumatoid factor activity.","volume":"40","author":"Meltzer","year":"1966","journal-title":"Am J Med"},{"key":"R12-5-20210128","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1182\/blood-2009-10-245878","article-title":"Pegylated interferon-alpha, ribavirin, and rituximab combined therapy of hepatitis C virus-related mixed cryoglobulinemia: a long-term study.","volume":"116","author":"Dammacco","year":"2010","journal-title":"Blood"},{"key":"R13-5-20210128","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1182\/blood-2009-10-248518","article-title":"Rituximab plus Peg-interferon-alpharibavirin compared with Peg-interferon-alpharibavirin in hepatitis C-related mixed cryoglobulinemia.","volume":"116","author":"Saadoun","year":"2010","journal-title":"Blood"},{"key":"R14-5-20210128","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1136\/ard.2011.150755","article-title":"Preliminary classification criteria for the cryoglobulinaemic vasculitis.","volume":"70","author":"De Vita","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"R15-5-20210128","first-page":"S48","article-title":"Performance of the preliminary classification criteria for cryoglobulinaemic vasculitis and clinical manifestations in hepatitis C virus-unrelated cryoglobulinaemic vasculitis.","volume":"30","author":"Quartuccio","year":"2012","journal-title":"Clin Exp Rheumatol"},{"key":"R16-5-20210128","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1038\/ki.1995.78","article-title":"Long-term predictors of survival in essential mixed cryoglobulinemic glomerulonephritis.","volume":"47","author":"Tarantino","year":"1995","journal-title":"Kidney Int"},{"key":"R17-5-20210128","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.semarthrit.2003.10.001","article-title":"Mixed cryoglobulinemia: demographic, clinical, and serologic features and survival in 231 patients.","volume":"33","author":"Ferri","year":"2004","journal-title":"Semin Arthritis Rheum"},{"key":"R18-5-20210128","first-page":"170","article-title":"Mortality rate and outcome factors in mixed cryoglobulinaemia: the impact of hepatitis C virus.","volume":"167-","author":"Della Rossa","year":"39","journal-title":"Scand J Rheumatol"},{"key":"R19-5-20210128","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/00005792-199601000-00003","article-title":"Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome: a prospective study in 342 patients.","volume":"75","author":"Guillevin","year":"1996","journal-title":"Medicine (Baltimore)"},{"key":"R20-5-20210128","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/MD.0b013e318205a4c6","article-title":"The Five-Factor Score revisited: assessment of prognoses of systemic necrotizing vasculitides based on the French Vasculitis Study Group (FVSG) cohort.","volume":"90","author":"Guillevin","year":"2011","journal-title":"Medicine (Baltimore)"},{"key":"R21-5-20210128","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/0002-9343(87)90904-1","article-title":"Treatment of idiopathic mixed cryoglobulinemia with alpha interferon.","volume":"83","author":"Bonomo","year":"1987","journal-title":"Am J Med"},{"key":"R22-5-20210128","doi-asserted-by":"crossref","first-page":"3317","DOI":"10.1002\/art.10699","article-title":"Interferon-alpha and ribavirin treatment in patients with hepatitis C virus-related systemic vasculitis.","volume":"46","author":"Cacoub","year":"2002","journal-title":"Arthritis Rheum"},{"key":"R23-5-20210128","doi-asserted-by":"crossref","first-page":"3696","DOI":"10.1002\/art.22168","article-title":"Antiviral therapy for hepatitis C virus--associated mixed cryoglobulinemia vasculitis: a long-term followup study.","volume":"54","author":"Saadoun","year":"2006","journal-title":"Arthritis Rheum"},{"key":"R24-5-20210128","doi-asserted-by":"crossref","first-page":"3865","DOI":"10.1182\/blood.V90.10.3865","article-title":"Predictors of long-term response to high-dose interferon therapy in type II cryoglobulinemia associated with hepatitis C virus infection.","volume":"90","author":"Casato","year":"1997","journal-title":"Blood"},{"key":"R25-5-20210128","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1056\/NEJM199403173301104","article-title":"Interferon alfa-2a therapy in cryoglobulinemia associated with hepatitis C virus.","volume":"330","author":"Misiani","year":"1994","journal-title":"N Engl J Med"},{"key":"R26-5-20210128","doi-asserted-by":"crossref","first-page":"3336","DOI":"10.1182\/blood.V84.10.3336.3336","article-title":"Natural interferon-alpha versus its combination with 6-methyl-prednisolone in the therapy of type II mixed cryoglobulinemia: a long-term, randomized, controlled study.","volume":"84","author":"Dammacco","year":"1994","journal-title":"Blood"},{"key":"R27-5-20210128","doi-asserted-by":"crossref","first-page":"3827","DOI":"10.1182\/blood-2002-09-2856","article-title":"Efficacy and safety of rituximab in type II mixed cryoglobulinemia.","volume":"101","author":"Zaja","year":"2003","journal-title":"Blood"},{"key":"R28-5-20210128","doi-asserted-by":"crossref","first-page":"3818","DOI":"10.1182\/blood-2002-10-3162","article-title":"Monoclonal antibody treatment of mixed cryoglobulinemia resistant to interferon alpha with an anti-CD20.","volume":"101","author":"Sansonno","year":"2003","journal-title":"Blood"},{"key":"R29-5-20210128","doi-asserted-by":"crossref","first-page":"3054","DOI":"10.1093\/ndt\/gfh469","article-title":"Long-term effects of anti-CD20 monoclonal antibody treatment of cryoglobulinaemic glomerulonephritis.","volume":"19","author":"Roccatello","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"R30-5-20210128","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1136\/ard.2007.081653","article-title":"Rituximab combined with Peg-interferon-ribavirin in refractory hepatitis C virus-associated cryoglobulinaemia vasculitis.","volume":"67","author":"Saadoun","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"R31-5-20210128","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1002\/art.24703","article-title":"Efficacy and tolerability of rituximab with or without PEGylated interferon alfa-2b plus ribavirin in severe hepatitis C virus-related vasculitis: a long-term followup study of thirty-two patients.","volume":"60","author":"Terrier","year":"2009","journal-title":"Arthritis Rheum"},{"key":"R32-5-20210128","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1002\/art.34331","article-title":"A randomized controlled trial of rituximab for the treatment of severe cryoglobulinemic vasculitis.","volume":"64","author":"De Vita","year":"2012","journal-title":"Arthritis Rheum"},{"key":"R33-5-20210128","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1002\/art.34322","article-title":"A randomized controlled trial of rituximab following failure of antiviral therapy for hepatitis C virus-associated cryoglobulinemic vasculitis.","volume":"64","author":"Sneller","year":"2012","journal-title":"Arthritis Rheum"},{"key":"R34-5-20210128","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1002\/acr.20318","article-title":"Safety and efficacy of rituximab in nonviral cryoglobulinemia vasculitis: data from the French Autoimmunity and Rituximab registry.","volume":"62","author":"Terrier","year":"2010","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"R35-5-20210128","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1002\/art.27555","article-title":"Risk factors for severe infections in patients with rheumatoid arthritis treated with rituximab in the autoimmunity and rituximab registry.","volume":"62","author":"Gottenberg","year":"2010","journal-title":"Arthritis Rheum"},{"key":"R37-5-20210128","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1093\/rheumatology\/keh503","article-title":"Rituximab inefficiency during type I cryoglobulinaemia.","volume":"44","author":"Nehme-Schuster","year":"2005","journal-title":"Rheumatology (Oxford)"},{"key":"R38-5-20210128","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/ncpneph0823","article-title":"Rituximab treatment for a patient with type I cryoglobulinemic glomerulonephritis.","volume":"4","author":"Pandrangi","year":"2008","journal-title":"Nat Clin Pract Nephrol"}],"container-title":["Current Opinion in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/BOR.0b013e32835b15f7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T23:04:44Z","timestamp":1620947084000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002281-201301000-00005"}},"subtitle":["an update"],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/bor.0b013e32835b15f7","relation":{},"ISSN":["1040-8711"],"issn-type":[{"value":"1040-8711","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]}}}